Advertisement

Topics

Migraine: Positive Topline Phase 3 Results for Lasmiditan

07:25 EDT 4 Aug 2017 | Medscape

The novel serotonin receptor agonist lasmiditan continues to show promise for acute treatment of migraine.
Medscape Medical News

Original Article: Migraine: Positive Topline Phase 3 Results for Lasmiditan

NEXT ARTICLE

More From BioPortfolio on "Migraine: Positive Topline Phase 3 Results for Lasmiditan"

Quick Search
Advertisement
 

Relevant Topics

Selective serotonin reuptake inhibitors SSRIs
Serotonin and norepinephrine reuptake inhibitors (SNRIs) are a class of medications that are effective at easing depression symptoms. SNRIs are also sometimes used to treat other conditions such as anxiety and nerve pain. How SNRIs work Serotonin (se...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...